Möbs C, Pfützner W
Klinisch-Experimentelle Allergologie, Allergiezentrum Hessen, Klinik für Dermatologie und Allergologie, Philipps‑Universität Marburg, Baldingerstr., 34043, Marburg, Deutschland.
Hautarzt. 2017 Jan;68(1):19-28. doi: 10.1007/s00105-016-3908-x.
Drug hypersensitivity reactions comprise approximately 25% of all adverse drug reactions and can be classified into allergic and pseudoallergic drug reactions. Immediate type anaphylactic and delayed type rash reactions of various clinical patterns can be distinguished, depending on the pathogenesis and clinical symptoms. The diagnostic work-up encompasses a thorough but also focused evaluation of the medical history, skin tests and when indicated challenge tests. Furthermore, in vitro tests, such as basophil activation tests and T cell assays not only add valuable additional information but can also yield decisive results for the diagnosis, especially in cases of severe drug reactions or reactions which cannot be further clarified by provocation tests. The aim of these measurements is not only the proof of drug intolerance and the detection of the causal drug but also the disclosure of the type of adverse reaction and the identification of potential, tolerated alternative drugs. This information is very important for the counseling of the patient and for prevention of new drug hypersensitivity reactions in the future.
药物过敏反应约占所有药物不良反应的25%,可分为过敏性和类过敏性药物反应。根据发病机制和临床症状,可区分出各种临床类型的速发型过敏反应和迟发型皮疹反应。诊断检查包括全面但有重点的病史评估、皮肤试验以及必要时的激发试验。此外,体外试验,如嗜碱性粒细胞活化试验和T细胞检测,不仅能提供有价值的额外信息,还可为诊断产生决定性结果,尤其是在严重药物反应或激发试验无法进一步明确的反应病例中。这些检测的目的不仅是证明药物不耐受和找出致病药物,还包括揭示不良反应的类型以及识别潜在的、可耐受的替代药物。这些信息对于患者咨询以及预防未来新的药物过敏反应非常重要。